Your browser doesn't support javascript.
loading
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens.
Crooks, Emma T; Almanza, Francisco; D'Addabbo, Alessio; Duggan, Erika; Zhang, Jinsong; Wagh, Kshitij; Mou, Huihui; Allen, Joel D; Thomas, Alyssa; Osawa, Keiko; Korber, Bette T; Tsybovsky, Yaroslav; Cale, Evan; Nolan, John; Crispin, Max; Verkoczy, Laurent K; Binley, James M.
Affiliation
  • Crooks ET; San Diego Biomedical Research Institute, San Diego, California, United States of America.
  • Almanza F; San Diego Biomedical Research Institute, San Diego, California, United States of America.
  • D'Addabbo A; School of Biological Sciences, University of Southampton, Southampton, United Kingdom.
  • Duggan E; Scintillon Institute, San Diego, California, United States of America.
  • Zhang J; Cellarcus BioSciences, La Jolla, California, United States of America.
  • Wagh K; San Diego Biomedical Research Institute, San Diego, California, United States of America.
  • Mou H; Theoretical Biology & Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
  • Allen JD; Department of Immunology and Microbial Science, The Scripps Research Institute, Jupiter, Florida, United States of America.
  • Thomas A; School of Biological Sciences, University of Southampton, Southampton, United Kingdom.
  • Osawa K; San Diego Biomedical Research Institute, San Diego, California, United States of America.
  • Korber BT; San Diego Biomedical Research Institute, San Diego, California, United States of America.
  • Tsybovsky Y; Theoretical Biology & Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
  • Cale E; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.
  • Nolan J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Crispin M; Scintillon Institute, San Diego, California, United States of America.
  • Verkoczy LK; Cellarcus BioSciences, La Jolla, California, United States of America.
  • Binley JM; School of Biological Sciences, University of Southampton, Southampton, United Kingdom.
PLoS Pathog ; 17(10): e1009807, 2021 10.
Article in En | MEDLINE | ID: mdl-34679128
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Envelope Protein gp41 / HIV Envelope Protein gp120 / HIV-1 / AIDS Vaccines Type of study: Prognostic_studies Limits: Humans Language: En Journal: PLoS Pathog Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Envelope Protein gp41 / HIV Envelope Protein gp120 / HIV-1 / AIDS Vaccines Type of study: Prognostic_studies Limits: Humans Language: En Journal: PLoS Pathog Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States